Ausler Snovy long-term strategy is to expand the product portfolio for all versions of blockbusters as well as to gradually offer a broader range of niche products within more narrow disease areas or to meet the demand for regional treatment principles.
| S.NO | BRAND NAME | COMPOSITION | PACKING |
| 1 | TELMISNOV-40 | Telmisartan40 mg | 10*10 |
| 2 | TELMISNOV-AM | Telmisartan 40mg +Amlodipine 5mg Tab | 10*10 |
| 3 | TELMISNOV-H | Telmisartan40mg+Hydrochloothiazide12.5mg | 10*10 |
| 4 | ATROSNOV-10 | Atorvastatin 10 mg | 10*10 |
| 5 | ATROSNOV-20 | Atorvastatin 20 mg | 10*10 |
| 6 | ATROSNOV-F | Atorvastatin 10 mg + Fenofibrate |
Ausler Snovy Healthcare
(A Division Of Zenacts Pharma)
Pankaj Kapoor (Managing Director)
SCF 331, 2nd Floor, Main Market, Manimajra Chandigarh- 160101, India
Ring : +91-9878941960
auslersnovyhealthcare@gmail.com
© 2015 Ausler Snovy Healthcare.
Developed by webtechINDIA